Pain Management

Prosecutors are bringing accountability to the opioid epidemic.

Results from new ASHP Survey.

Patient data provides a rich resource that can help address the problem of opioid misuse and addiction among their health plan members.

Virus-like particle research could lead to a vaccine against opioid addiction.

Organization calls for state-level legislative and regulatory revisions.

Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.

The action by the U.S. Attorney's Office is the latest in legal and policy maneuvers aimed at ending the opioid epidemic.

Results from IQVIA Institute for Human Data Science's annual report, "Medicine Use and Spending in the U.S."

Physicians have been misapplying the CDC’s 2016 opioid prescribing guideline, causing challenges for some pain patients, according to a new commentary.

The campaign places emphasis on Americans' role in proper removal and disposal of opioids from their home.

As the U.S. opioid addiction crisis continues to worsen, the pharmacy industry’s role in addressing the epidemic continues to increase.

By heading off the misuse of unused medications, pharmacists can play a key role in combatting opioid diversion, accidental poisonings and environmental pollution.

FDA granted final approval to drug originally tentatively approved in 2018.

Progressive Ohio law adds pharmacists as a key patient care team member.

Increasing death tolls have prompted significant initiatives from governmental agencies.

What one pharmacist says the AAOA Pharmacy Toolkit can do to help combat the opioid epidemic. 

Changes coming to combat opioid addictions and overuse, as well as mitigate rising drug prices. 

Health systems employ Artifical Intelligence and integrated medication management to address diversion.

CVS vs Amazon, Naxolone, and more. 

CVS health care defended itself after the drugstore chain and Walgreens were added to a Florida lawsuit alleging that they failed to stop suspicious opioid prescriptions.

As federal and other regulations on opioid pain relievers are changing, NCPA presented a panel discussion on “Opioid Pain Management and Your Pharmacy” at its Annual Convention in Boston.

A new FDA plan will offer new education opportunities for a variety of healthcare workers.

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

The September Small Doses brings you the latest news that affects pharmacists.